World-first method streamlines process of identifying structure and molecular weight of compounds.

Scientists develop low-cost platform which could detect early cancer

New research reveals lowering cholesterol could potentially prevent or help stop the spread of prostate cancer.

A new method of identifying molecular targets to fight disease could help accelerate future drug development new Griffith University research has found.

2021 Australia Day honours have been bestowed upon a number of Griffith University staff, associates and alumni. 

New details of the promising Oxford AstraZeneca vaccine signals hope for 2021 … but what does this actually mean for the general population?

An Australian-first rehabilitation trial considered the next crucial step in treating paralysis will proceed after a record donation from the country’s leading spinal injury research foundation.

Griffith University researchers have been awarded a $640,000 Australian Research Council Linkage grant to develop an indicator of nutrient-runoff essential for accurate nutrient trading schemes.

One of Griffith’s biggest supporters in the field of spinal cord injury research and a Griffith Sciences alumnus have been recognised at the Queensland Community Foundation Philanthropy awards.

Professor Katherine Andrews, Director of the Griffith Institute for Drug Discovery (GRIDD), has been recognised as a Fellow of the Australian Society for Parasitology for her work on malaria drug discovery.

A new anti-cancer drug for prostate cancer overcomes the twin problems plaguing researchers for decades. It halts metastasis (tumour spread) and drug resistance.

The Queensland Government has awarded $1.875 million in funding to Compounds Australia.

Scientists at Griffith University are moving towards animal trials in testing a vaccine candidate for COVID-19

New research from Griffith University has shown that damage to the lining inside the nose increases the risk of bacteria sneaking into the brain via nerves, potentially causing long-term health issues. PhD candidate Heidi Walkden and her colleagues from the Menzies Health Institute Queensland, Institute for Glycomics and Griffith Institute for Drug Discovery, in collaboration with Queensland […]

A team of Griffith University researchers has won the prestigious Marshall and Warren Innovation Award at the annual NHMRC Research Excellence Awards.

Leading drug discovery institute announced new member of the Association of Australian Medical Research Institutes. 

First large epigenome-wide study to compare changes between people with Parkinson’s and those without disease.

World-leading Griffith research into the development of a cell-based therapy for treating spinal cord injuries has received a $5.7m boost from the state government.